Pyridine Derivatives and Furan Derivatives Identified From the Medicinal Mushroom Irpex lacteus SY1002
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202403124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Guihong Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Shandong Province Key Laboratory of Applied Mycology, and Qingdao International Center on Microbes Utilizing Biogas, Qingdao…. Hauptthemen laut MEDLINE: Pyridines, Furans, Angiotensin-Converting Enzyme Inhibitors, Agaricales. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, China, Shandong Provincial Key Research and Development Plan, High-level Talents Research Fund of Qingdao Agricultural University.
Abstract (Originalsprache)
Three new pyridine derivatives, irpelactedines A–C ( 1 – 3 ), and a new furan derivative, irpelactedine D ( 5 ), along with two structurally related known compounds, irpexidine A ( 4 ) and 5‐carboxy‐2‐furanpropanoic acid ( 6 ), were isolated from the medicinal fungus Irpex lacteus SY1002. Their structures were elucidated through nuclear magnetic resonance and mass spectral analyses, combined with density functional theory calculations of electronic circular dichroism data. Evaluation of angiotensin‐converting enzyme (ACE) inhibitory activity revealed that compounds 1 and 3 displayed moderate inhibition, with IC 50 values of 31.49 ± 3.41 and 80.96 ± 6.93 µg/mL, respectively. Molecular docking suggested that compound 1 is bound to the active site of ACE, leading to a reduction in its activity. Furthermore, cytotoxicity and antimicrobial activity tests revealed the low toxicity of these compounds. This is the first report on the ACE inhibitory activity of this class of pyridine derivatives, providing valuable insights into exploring the medicinal potential of I. lacteus and offering a structural template for developing new ACE inhibitors. Future efforts will focus on optimizing their structure and conducting in vivo testing to assess their therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Shandong Province Key Laboratory of Applied Mycology, and Qingdao International Center on Microbes Utilizing Biogas, Qingdao Agricultural University, Qingdao, Shandong, China.
- Jiangsu Key Laboratory of Marine Bioresources and Environment, Jiangsu Ocean University, Lianyungang, Jiangsu, China.
- Key Laboratory of Testing and Evaluation for Aquatic Product Safety and Quality, Ministry of Agriculture and Rural Affairs, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao, Shandong…
ORCID-Profile: Guihong Yu
Förderung
- Natural Science Foundation of Shandong Province, China
- Shandong Provincial Key Research and Development Plan
- High-level Talents Research Fund of Qingdao Agricultural University
- Open-end Funds of Jiangsu Key Laboratory of Marine Bioresources and Environment
Zitieren
APA
Yu, G., Shang, Z., Li, W., Peng, J., Mo, X., Yang, S., & Tan, L. (2025). Pyridine Derivatives and Furan Derivatives Identified From the Medicinal Mushroom Irpex lacteus SY1002. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202403124
Vancouver
Yu G, Shang Z, Li W, Peng J, Mo X, Yang S, et al. Pyridine Derivatives and Furan Derivatives Identified From the Medicinal Mushroom Irpex lacteus SY1002. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202403124
BibTeX
@article{Yu2025,
author = {Yu, Guihong and Shang, Zhaomeng and Li, Wanting and Peng, Jixing and Mo, Xuhua and Yang, Song and Tan, Lingling},
title = {Pyridine Derivatives and Furan Derivatives Identified From the Medicinal Mushroom Irpex lacteus SY1002},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202403124}
}
EUVIMED